SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000891293-21-000044
Filing Date
2021-11-12
Accepted
2021-11-12 17:03:34
Documents
44
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ctic-20210930.htm   iXBRL 10-Q 954621
2 EX-10.1 exhibit101dripurchaseandsa.htm EX-10.1 402284
3 EX-10.2 exhibit102dricreditagreeme.htm EX-10.2 1110973
4 EX-31.1 ex311-ceo302q3fy211.htm EX-31.1 11340
5 EX-31.2 ex312-cfo302q3fy211.htm EX-31.2 12208
6 EX-32 ex32-ceocfo906q3fy211.htm EX-32 11666
  Complete submission text file 0000891293-21-000044.txt   5785438

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctic-20210930.xsd EX-101.SCH 27757
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctic-20210930_cal.xml EX-101.CAL 50215
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctic-20210930_def.xml EX-101.DEF 168579
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ctic-20210930_lab.xml EX-101.LAB 371336
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctic-20210930_pre.xml EX-101.PRE 229906
12 EXTRACTED XBRL INSTANCE DOCUMENT ctic-20210930_htm.xml XML 520812
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-28386 | Film No.: 211404667
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences